Global General Anesthesia Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 14-Sep-2022
No. of pages: 119
Inquire Before Buying

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global General Anesthesia Drugs market is projected to reach US$ 9088 million by 2028 from an estimated US$ 7745.4 million in 2022, at a CAGR of 2.7% during 2023 and 2028.

The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding General Anesthesia Drugs.

The General Anesthesia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global General Anesthesia Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the General Anesthesia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Astrazeneca

- Fresenius-Kabi

- AbbVie

- Baxter Healthcare

- B.Braun

- Maruishi

- Piramal

- Hikma Pharmaceuticals

- Mylan

- Nhwa

- Hengrui

- Lunan

Product Type Insights

Global markets are presented by General Anesthesia Drugs type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the General Anesthesia Drugs are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

General Anesthesia Drugs Segment by Type

- Propofol

- Etomidate

- Midazolam

- Sevoflurane

- Isoflurane

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the General Anesthesia Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the General Anesthesia Drugs market.

General Anesthesia Drugs Segment by Application

- Intravenous Anesthetics

- Inhalational Anesthetics

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the General Anesthesia Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the General Anesthesia Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthesia Drugs

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global General Anesthesia Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 General Anesthesia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global General Anesthesia Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 Market by Application
1.3.1 Global General Anesthesia Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global General Anesthesia Drugs Market Size Estimates and Forecasts
2.1.1 Global General Anesthesia Drugs Revenue 2017-2028
2.1.2 Global General Anesthesia Drugs Sales 2017-2028
2.2 General Anesthesia Drugs Market Size by Region: 2022 Versus 2028
2.3 General Anesthesia Drugs Sales by Region (2017-2028)
2.3.1 Global General Anesthesia Drugs Sales by Region: 2017-2022
2.3.2 Global General Anesthesia Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global General Anesthesia Drugs Sales Market Share by Region (2017-2028)
2.4 General Anesthesia Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global General Anesthesia Drugs Revenue by Region: 2017-2022
2.4.2 Global General Anesthesia Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global General Anesthesia Drugs Revenue Market Share by Region (2017-2028)
3 Global General Anesthesia Drugs by Manufacturers
3.1 Global Top General Anesthesia Drugs Manufacturers by Sales
3.1.1 Global General Anesthesia Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top General Anesthesia Drugs Manufacturers by Revenue
3.2.1 Global General Anesthesia Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global General Anesthesia Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global General Anesthesia Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key General Anesthesia Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global General Anesthesia Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global General Anesthesia Drugs Manufacturing Base Distribution, Product Type
3.5.1 General Anesthesia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers General Anesthesia Drugs Product Type
3.5.3 Date of International Manufacturers Enter into General Anesthesia Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Astrazeneca
4.1.1 Astrazeneca Corporation Information
4.1.2 Astrazeneca Description, Business Overview
4.1.3 Astrazeneca General Anesthesia Drugs Products Offered
4.1.4 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Astrazeneca General Anesthesia Drugs Sales by Product in 2021
4.1.6 Astrazeneca General Anesthesia Drugs Sales by Application in 2021
4.1.7 Astrazeneca General Anesthesia Drugs Sales by Geographic Area in 2021
4.1.8 Astrazeneca Recent Developments
4.2 Fresenius-Kabi
4.2.1 Fresenius-Kabi Corporation Information
4.2.2 Fresenius-Kabi Description, Business Overview
4.2.3 Fresenius-Kabi General Anesthesia Drugs Products Offered
4.2.4 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Fresenius-Kabi General Anesthesia Drugs Sales by Product in 2021
4.2.6 Fresenius-Kabi General Anesthesia Drugs Sales by Application in 2021
4.2.7 Fresenius-Kabi General Anesthesia Drugs Sales by Geographic Area in 2021
4.2.8 Fresenius-Kabi Recent Developments
4.3 AbbVie
4.3.1 AbbVie Corporation Information
4.3.2 AbbVie Description, Business Overview
4.3.3 AbbVie General Anesthesia Drugs Products Offered
4.3.4 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 AbbVie General Anesthesia Drugs Sales by Product in 2021
4.3.6 AbbVie General Anesthesia Drugs Sales by Application in 2021
4.3.7 AbbVie General Anesthesia Drugs Sales by Geographic Area in 2021
4.3.8 AbbVie Recent Developments
4.4 Baxter Healthcare
4.4.1 Baxter Healthcare Corporation Information
4.4.2 Baxter Healthcare Description, Business Overview
4.4.3 Baxter Healthcare General Anesthesia Drugs Products Offered
4.4.4 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Baxter Healthcare General Anesthesia Drugs Sales by Product in 2021
4.4.6 Baxter Healthcare General Anesthesia Drugs Sales by Application in 2021
4.4.7 Baxter Healthcare General Anesthesia Drugs Sales by Geographic Area in 2021
4.4.8 Baxter Healthcare Recent Developments
4.5 B.Braun
4.5.1 B.Braun Corporation Information
4.5.2 B.Braun Description, Business Overview
4.5.3 B.Braun General Anesthesia Drugs Products Offered
4.5.4 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 B.Braun General Anesthesia Drugs Sales by Product in 2021
4.5.6 B.Braun General Anesthesia Drugs Sales by Application in 2021
4.5.7 B.Braun General Anesthesia Drugs Sales by Geographic Area in 2021
4.5.8 B.Braun Recent Developments
4.6 Maruishi
4.6.1 Maruishi Corporation Information
4.6.2 Maruishi Description, Business Overview
4.6.3 Maruishi General Anesthesia Drugs Products Offered
4.6.4 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Maruishi General Anesthesia Drugs Sales by Product in 2021
4.6.6 Maruishi General Anesthesia Drugs Sales by Application in 2021
4.6.7 Maruishi General Anesthesia Drugs Sales by Geographic Area in 2021
4.6.8 Maruishi Recent Development
4.7 Piramal
4.7.1 Piramal Corporation Information
4.7.2 Piramal Description, Business Overview
4.7.3 Piramal General Anesthesia Drugs Products Offered
4.7.4 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Piramal General Anesthesia Drugs Sales by Product in 2021
4.7.6 Piramal General Anesthesia Drugs Sales by Application in 2021
4.7.7 Piramal General Anesthesia Drugs Sales by Geographic Area in 2021
4.7.8 Piramal Recent Development
4.8 Hikma Pharmaceuticals
4.8.1 Hikma Pharmaceuticals Corporation Information
4.8.2 Hikma Pharmaceuticals Description, Business Overview
4.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Products Offered
4.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Hikma Pharmaceuticals General Anesthesia Drugs Sales by Product in 2021
4.8.6 Hikma Pharmaceuticals General Anesthesia Drugs Sales by Application in 2021
4.8.7 Hikma Pharmaceuticals General Anesthesia Drugs Sales by Geographic Area in 2021
4.8.8 Hikma Pharmaceuticals Recent Development
4.9 Mylan
4.9.1 Mylan Corporation Information
4.9.2 Mylan Description, Business Overview
4.9.3 Mylan General Anesthesia Drugs Products Offered
4.9.4 Mylan General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Mylan General Anesthesia Drugs Sales by Product in 2021
4.9.6 Mylan General Anesthesia Drugs Sales by Application in 2021
4.9.7 Mylan General Anesthesia Drugs Sales by Geographic Area in 2021
4.9.8 Mylan Recent Development
4.10 Nhwa
4.10.1 Nhwa Corporation Information
4.10.2 Nhwa Description, Business Overview
4.10.3 Nhwa General Anesthesia Drugs Products Offered
4.10.4 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Nhwa General Anesthesia Drugs Sales by Product in 2021
4.10.6 Nhwa General Anesthesia Drugs Sales by Application in 2021
4.10.7 Nhwa General Anesthesia Drugs Sales by Geographic Area in 2021
4.10.8 Nhwa Recent Development
4.11 Hengrui
4.11.1 Hengrui Corporation Information
4.11.2 Hengrui Description, Business Overview
4.11.3 Hengrui General Anesthesia Drugs Products Offered
4.11.4 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Hengrui General Anesthesia Drugs Sales by Product in 2021
4.11.6 Hengrui General Anesthesia Drugs Sales by Application in 2021
4.11.7 Hengrui General Anesthesia Drugs Sales by Geographic Area in 2021
4.11.8 Hengrui Recent Development
4.12 Lunan
4.12.1 Lunan Corporation Information
4.12.2 Lunan Description, Business Overview
4.12.3 Lunan General Anesthesia Drugs Products Offered
4.12.4 Lunan General Anesthesia Drugs Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Lunan General Anesthesia Drugs Sales by Product in 2021
4.12.6 Lunan General Anesthesia Drugs Sales by Application in 2021
4.12.7 Lunan General Anesthesia Drugs Sales by Geographic Area in 2021
4.12.8 Lunan Recent Development
5 Breakdown Data by Type
5.1 Global General Anesthesia Drugs Sales by Type (2017-2028)
5.1.1 Global General Anesthesia Drugs Sales by Type (2017-2022)
5.1.2 Global General Anesthesia Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global General Anesthesia Drugs Sales Market Share by Type (2017-2028)
5.2 Global General Anesthesia Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global General Anesthesia Drugs Revenue by Type (2017-2022)
5.2.2 Global General Anesthesia Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global General Anesthesia Drugs Revenue Market Share by Type (2017-2028)
5.3 General Anesthesia Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global General Anesthesia Drugs Sales by Application (2017-2028)
6.1.1 Global General Anesthesia Drugs Sales by Application (2017-2022)
6.1.2 Global General Anesthesia Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global General Anesthesia Drugs Sales Market Share by Application (2017-2028)
6.2 Global General Anesthesia Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global General Anesthesia Drugs Revenue by Application (2017-2022)
6.2.2 Global General Anesthesia Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global General Anesthesia Drugs Revenue Market Share by Application (2017-2028)
6.3 General Anesthesia Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America General Anesthesia Drugs Market Size YoY Growth 2017-2028
7.2 North America General Anesthesia Drugs Market Facts & Figures by Country
7.2.1 North America General Anesthesia Drugs Sales by Country (2017-2028)
7.2.2 North America General Anesthesia Drugs Revenue by Country (2017-2028)
7.3 North America General Anesthesia Drugs Sales by Type
7.4 North America General Anesthesia Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific General Anesthesia Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific General Anesthesia Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific General Anesthesia Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific General Anesthesia Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific General Anesthesia Drugs Sales by Type
8.4 Asia-Pacific General Anesthesia Drugs Sales by Application
9 Europe
9.1 Europe General Anesthesia Drugs Market Size YoY Growth 2017-2028
9.2 Europe General Anesthesia Drugs Market Facts & Figures by Country
9.2.1 Europe General Anesthesia Drugs Sales by Country (2017-2028)
9.2.2 Europe General Anesthesia Drugs Revenue by Country (2017-2028)
9.3 Europe General Anesthesia Drugs Sales by Type
9.4 Europe General Anesthesia Drugs Sales by Application
10 Latin America
10.1 Latin America General Anesthesia Drugs Market Size YoY Growth 2017-2028
10.2 Latin America General Anesthesia Drugs Market Facts & Figures by Country
10.2.1 Latin America General Anesthesia Drugs Sales by Country (2017-2028)
10.2.2 Latin America General Anesthesia Drugs Revenue by Country (2017-2028)
10.3 Latin America General Anesthesia Drugs Sales by Type
10.4 Latin America General Anesthesia Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa General Anesthesia Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa General Anesthesia Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa General Anesthesia Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa General Anesthesia Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa General Anesthesia Drugs Sales by Type
11.4 Middle East and Africa General Anesthesia Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 General Anesthesia Drugs Supply Chain Analysis
12.2 General Anesthesia Drugs Key Raw Materials and Upstream Suppliers
12.3 General Anesthesia Drugs Clients Analysis
12.4 General Anesthesia Drugs Sales Channel and Sales Model Analysis
12.4.1 General Anesthesia Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 General Anesthesia Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 General Anesthesia Drugs Distributors
13 Market Dynamics
13.1 General Anesthesia Drugs Industry Trends
13.2 General Anesthesia Drugs Market Drivers
13.3 General Anesthesia Drugs Market Challenges
13.4 General Anesthesia Drugs Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global General Anesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Propofol
Table 3. Major Manufacturers of Etomidate
Table 4. Major Manufacturers of Midazolam
Table 5. Major Manufacturers of Sevoflurane
Table 6. Major Manufacturers of Isoflurane
Table 7. Major Manufacturers of Others
Table 8. Global General Anesthesia Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global General Anesthesia Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 10. Global General Anesthesia Drugs Sales by Region (2017-2022) & (K Units)
Table 11. Global General Anesthesia Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global General Anesthesia Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global General Anesthesia Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global General Anesthesia Drugs Sales by Manufacturer (2017-2022) & (K Units)
Table 15. Global General Anesthesia Drugs Sales Share by Manufacturer (2017-2022)
Table 16. General Anesthesia Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 17. General Anesthesia Drugs Revenue Share by Manufacturer (2017-2022)
Table 18. Key Manufacturers General Anesthesia Drugs Price (2017-2022) & (USD/Unit)
Table 19. Ranking of Global Top General Anesthesia Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 20. Global General Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 21. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in General Anesthesia Drugs as of 2021)
Table 22. General Anesthesia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers General Anesthesia Drugs Product Type
Table 24. Date of International Manufacturers Enter into General Anesthesia Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Astrazeneca Corporation Information
Table 27. Astrazeneca Description and Business Overview
Table 28. Astrazeneca General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 29. Astrazeneca General Anesthesia Drugs Product
Table 30. Astrazeneca General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 31. Astrazeneca General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 32. Astrazeneca General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 33. Astrazeneca Recent Development
Table 34. Fresenius-Kabi Corporation Information
Table 35. Fresenius-Kabi Description and Business Overview
Table 36. Fresenius-Kabi General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 37. Fresenius-Kabi General Anesthesia Drugs Product
Table 38. Fresenius-Kabi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 39. Fresenius-Kabi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 40. Fresenius-Kabi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 41. Fresenius-Kabi Recent Development
Table 42. AbbVie Corporation Information
Table 43. AbbVie Description and Business Overview
Table 44. AbbVie General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. AbbVie General Anesthesia Drugs Product
Table 46. AbbVie General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 47. AbbVie General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 48. AbbVie General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 49. AbbVie Recent Development
Table 50. Baxter Healthcare Corporation Information
Table 51. Baxter Healthcare Description and Business Overview
Table 52. Baxter Healthcare General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Baxter Healthcare General Anesthesia Drugs Product
Table 54. Baxter Healthcare General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 55. Baxter Healthcare General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 56. Baxter Healthcare General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 57. Baxter Healthcare Recent Development
Table 58. B.Braun Corporation Information
Table 59. B.Braun Description and Business Overview
Table 60. B.Braun General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 61. B.Braun General Anesthesia Drugs Product
Table 62. B.Braun General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 63. B.Braun General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 64. B.Braun General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 65. B.Braun Recent Development
Table 66. Maruishi Corporation Information
Table 67. Maruishi Description and Business Overview
Table 68. Maruishi General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 69. Maruishi General Anesthesia Drugs Product
Table 70. Maruishi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 71. Maruishi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 72. Maruishi General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 73. Piramal Corporation Information
Table 74. Piramal Description and Business Overview
Table 75. Piramal General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 76. Piramal General Anesthesia Drugs Product
Table 77. Piramal General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 78. Piramal General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 79. Piramal General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 80. Hikma Pharmaceuticals Corporation Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 83. Hikma Pharmaceuticals General Anesthesia Drugs Product
Table 84. Hikma Pharmaceuticals General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 85. Hikma Pharmaceuticals General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 86. Hikma Pharmaceuticals General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 87. Mylan Corporation Information
Table 88. Mylan Description and Business Overview
Table 89. Mylan General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Mylan General Anesthesia Drugs Product
Table 91. Mylan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 92. Mylan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 93. Mylan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 94. Nhwa Corporation Information
Table 95. Nhwa Description and Business Overview
Table 96. Nhwa General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Nhwa General Anesthesia Drugs Product
Table 98. Nhwa General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 99. Nhwa General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 100. Nhwa General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 101. Hengrui Corporation Information
Table 102. Hengrui Description and Business Overview
Table 103. Hengrui General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 104. Hengrui General Anesthesia Drugs Product
Table 105. Hengrui General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 106. Hengrui General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 107. Hengrui General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 108. Lunan Corporation Information
Table 109. Lunan Description and Business Overview
Table 110. Lunan General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Lunan General Anesthesia Drugs Product
Table 112. Lunan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Product in 2021
Table 113. Lunan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Application in 2021
Table 114. Lunan General Anesthesia Drugs Sales Proportion of General Anesthesia Drugs by Geographic Area in 2021
Table 115. Global General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 116. Global General Anesthesia Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 117. Global General Anesthesia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 118. Global General Anesthesia Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 119. Global General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 120. Global General Anesthesia Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 121. Global General Anesthesia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 122. Global General Anesthesia Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 123. North America General Anesthesia Drugs Sales by Country (2017-2022) & (K Units)
Table 124. North America General Anesthesia Drugs Sales by Country (2023-2028) & (K Units)
Table 125. North America General Anesthesia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 126. North America General Anesthesia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 127. North America General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 128. North America General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific General Anesthesia Drugs Sales by Region (2017-2022) & (K Units)
Table 130. Asia-Pacific General Anesthesia Drugs Sales by Region (2023-2028) & (K Units)
Table 131. Asia-Pacific General Anesthesia Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 132. Asia-Pacific General Anesthesia Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 133. Asia-Pacific General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 134. Asia-Pacific General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 135. Europe General Anesthesia Drugs Sales by Country (2017-2022) & (K Units)
Table 136. Europe General Anesthesia Drugs Sales by Country (2023-2028) & (K Units)
Table 137. Europe General Anesthesia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 138. Europe General Anesthesia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 139. Europe General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 140. Europe General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 141. Latin America General Anesthesia Drugs Sales by Country (2017-2022) & (K Units)
Table 142. Latin America General Anesthesia Drugs Sales by Country (2023-2028) & (K Units)
Table 143. Latin America General Anesthesia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 144. Latin America General Anesthesia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 145. Latin America General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 146. Latin America General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 147. Middle East and Africa General Anesthesia Drugs Sales by Country (2017-2022) & (K Units)
Table 148. Middle East and Africa General Anesthesia Drugs Sales by Country (2023-2028) & (K Units)
Table 149. Middle East and Africa General Anesthesia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 150. Middle East and Africa General Anesthesia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 151. Middle East and Africa General Anesthesia Drugs Sales by Type (2017-2022) & (K Units)
Table 152. Middle East and Africa General Anesthesia Drugs Sales by Application (2017-2022) & (K Units)
Table 153. General Anesthesia Drugs Key Raw Materials, Industry Status and Trend
Table 154. General Anesthesia Drugs Key Raw Materials and Upstream Suppliers
Table 155. General Anesthesia Drugs Clients Status and Trend
Table 156. General Anesthesia Drugs Typical Clients
Table 157. General Anesthesia Drugs Distributors
Table 158. General Anesthesia Drugs Market Trends
Table 159. General Anesthesia Drugs Market Drivers
Table 160. General Anesthesia Drugs Market Challenges
Table 161. General Anesthesia Drugs Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. General Anesthesia Drugs Product Picture
Figure 2. Global General Anesthesia Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Propofol Product Picture
Figure 4. Etomidate Product Picture
Figure 5. Midazolam Product Picture
Figure 6. Sevoflurane Product Picture
Figure 7. Isoflurane Product Picture
Figure 8. Others Product Picture
Figure 9. Global General Anesthesia Drugs Sales Market Share by Application in 2021 & 2028
Figure 10. Intravenous Anesthetics Examples
Figure 11. Inhalational Anesthetics Examples
Figure 12. General Anesthesia Drugs Report Years Considered
Figure 13. Global General Anesthesia Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global General Anesthesia Drugs Market Size 2017-2028 (US$ Million)
Figure 15. Global General Anesthesia Drugs Sales 2017-2028 (K Units)
Figure 16. Global General Anesthesia Drugs Market Size Market Share by Region: 2022 Versus 2028
Figure 17. Global General Anesthesia Drugs Sales Market Share Forecast by Region (2017-2028)
Figure 18. Global General Anesthesia Drugs Revenue Market Share by Region (2017-2028)
Figure 19. Global General Anesthesia Drugs Sales Share by Manufacturer in 2021
Figure 20. General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global General Anesthesia Drugs Sales Market Share Forecast by Type (2017-2028)
Figure 22. Global General Anesthesia Drugs Revenue Market Share Forecast by Type (2017-2028)
Figure 23. General Anesthesia Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 24. Global General Anesthesia Drugs Sales Market Share Forecast by Application (2017-2028)
Figure 25. Global General Anesthesia Drugs Revenue Market Share Forecast by Application (2017-2028)
Figure 26. General Anesthesia Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 27. North America General Anesthesia Drugs Revenue 2017-2028 (US$ Million)
Figure 28. North America General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Figure 29. North America General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Figure 30. Asia-Pacific General Anesthesia Drugs Revenue 2017-2028 (US$ Million)
Figure 31. Asia-Pacific General Anesthesia Drugs Sales Market Share by Region (2017-2028)
Figure 32. Asia-Pacific General Anesthesia Drugs Revenue Market Share by Region (2017-2028)
Figure 33. Asia-Pacific General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Figure 34. Asia-Pacific General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Figure 35. Europe General Anesthesia Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 36. Europe General Anesthesia Drugs Sales Market Share by Country (2017-2028)
Figure 37. Europe General Anesthesia Drugs Revenue Market Share by Country (2017-2028)
Figure 38. Europe General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Figure 39. Europe General Anesthesia
  • Global Sevoflurane Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Sevoflurane market size was valued at US$ 1293.8 million in 2023. With growing demand in downstream market, the Sevoflurane is forecast to a readjusted size of US$ 1247.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Sevoflurane market. Sevoflurane are expected to show stable growth in the future market. However, product differentiation, reducing c......
  • Global Remifentanil Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Remifentanil Hydrochloride market size was valued at US$ million in 2023. With growing demand in downstream market, the Remifentanil Hydrochloride is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Remifentanil Hydrochloride market. Remifentanil Hydrochloride are expected to show stable growth in the future market. How......
  • Global General Anesthesia Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global General Anesthesia Drugs market size was valued at US$ 3840.3 million in 2023. With growing demand in downstream market, the General Anesthesia Drugs is forecast to a readjusted size of US$ 4929.3 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global General Anesthesia Drugs market. General Anesthesia Drugs are expected to show stable growth in the future m......
  • Global Sevoflurane Source Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Sevoflurane Source market size was valued at US$ 1192.7 million in 2023. With growing demand in downstream market, the Sevoflurane Source is forecast to a readjusted size of US$ 1509.6 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Sevoflurane Source market. Sevoflurane Source are expected to show stable growth in the future market. However, product ......
  • Global Anesthesia Drugs Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 166
    Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
  • Global Anesthesia Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 108
    Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
  • Global Sevoflurane Professional Survey Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 109
    Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
  • Global Sevoflurane Market Research Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 132
    Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
  • Global Sevoflurane Source Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Sevoflurane Source is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerg......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs